Thomas J. Schall
Director · Immuneering Corp
- 2026
- Jun 11, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas J. Schall files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Feinberg - $87K in IMRX purchases and sales in the last 12 months
- Brett Matthew Hall - $36K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Benjamin J. Zeskind - $11K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas J. Schall?
Thomas J. Schall is a corporate insider, tracked as Director of Immuneering Corp (IMRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Thomas J. Schall last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 2 filings going back to 2026.
Has Thomas J. Schall been buying or selling stock?
Recorded transactions: 1 open-market purchase ($101K) and 0 open-market sales across all tracked filings.
